DR

Divyakolu Ramanjaneyulu

Active Director Director DIN 08101455
DIN 08101455 First appointment Apr 2018 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 2018
Shareholding value •••• Premium profile

About Divyakolu Ramanjaneyulu

Data last updated:

Divyakolu Ramanjaneyulu has 8 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Vande Bharat Pharmaceuticals Private Limited and Italian Remedies Private Limited. Formerly with 2 companies, such as Leogenic Healthcare Private Limited and Leogenic Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹14.27 Cr; the largest is Okinawa Pharmaceuticals Private Limited at ₹14.10 Cr (FY 2025).

DIN 08101455
Primary Designation Director
First Appointment 03 Apr 2018
Oldest Company Age 10 yrs
Largest company Okinawa Pharmaceuticals Private Limited · ₹14.10 Cr (FY 2025)
Combined revenue ₹14.27 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director04 Apr 20242015₹14.10 Cr (FY 2025)Active
Italian Remedies Private Limited U65929TG2021PTC147555
Director24 Feb 20242021₹17.6 Lakh (FY 2025)Active
Director29 Jan 20252025–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Leogenic Healthcare Private Limited U85320MH2018PTC308093
Director16 Apr 20182018₹5.93 Cr (FY 2020)Active
Leogenic Pharma Private Limited U24304TG2018PTC123511
Director03 Apr 20182018₹5,000 (FY 2019)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vande Bharat Pharmaceuticals Private Limited
Italian Remedies Private Limited
Okinawa Pharmaceuticals Private Limited
Leogenic Healthcare Private Limited
Premium access

Shareholding and investment profile for Divyakolu Ramanjaneyulu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Divyakolu Ramanjaneyulu

Divyakolu Ramanjaneyulu has 8 years in corporate governance. Holds Director and Additional Director roles. Currently with 3 companies, including Vande Bharat Pharmaceuticals Private Limited and Italian Remedies Private Limited. Formerly with 2 companies, such as Leogenic Healthcare Private Limited and Leogenic Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹14.27 Cr; the largest is Okinawa Pharmaceuticals Private Limited at ₹14.10 Cr (FY 2025).

Divyakolu Ramanjaneyulu is associated with 3 companies as Director and Additional Director, including Okinawa Pharmaceuticals Private Limited (₹14.10 Cr), Italian Remedies Private Limited (₹17.6 Lakh), Vande Bharat Pharmaceuticals Private Limited.

Divyakolu Ramanjaneyulu has expertise in General Business, Healthcare.

Divyakolu Ramanjaneyulu has 8 years in corporate governance.

By reported revenue, the largest current company of Divyakolu Ramanjaneyulu is Okinawa Pharmaceuticals Private Limited, with revenue of ₹14.10 Cr (FY 2025).

The 2 current companies of Divyakolu Ramanjaneyulu that report revenue have a combined latest revenue of ₹14.27 Cr.

Divyakolu Ramanjaneyulu currently holds positions at 3 companies: Okinawa Pharmaceuticals Private Limited (₹14.10 Cr), Italian Remedies Private Limited (₹17.6 Lakh), Vande Bharat Pharmaceuticals Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available